Parkinson's disease is a progressive neurodegenerative disease of the basal ganglia.
Pathologically, it is characterized by continuous dopaminergic cell loss in the nigrostriatal …

In Parkinson's disease a dopaminergic/cholinergic and a GABAergic/glutaminergic
neurotransmitter imbalance occurs in the extrapyramidal system. Here, in this system, we …

Parkinson's disease is primarily characterised by degeneration of the nigrostriatal
dopaminergic pathways in the basal ganglia. However, non-dopaminergic …

Parkinson's disease (PD) is most frequently associated with characteristic motor symptoms
that are known to arise with degeneration of dopaminergic neurons. However, patients with …

Parkinson's disease (PD) is a common age-related neurodegenerative disorder, second
only to Alzheimer's disease (AD). It is named in honor of James Parkinson, who provided a …

Parkinson's disease is a progressive neurodegenerative disorder. The classical motor
symptoms include resting tremors, bradykinesia, rigidity and postural instability and are …

For several decades, the dopamine precursor levodopa has been the primary therapy for
Parkinson's disease (PD). However, not all of the motor and non-motor features of PD can …

This collection presents an array of articles addressing the non-dopaminergic mechanisms
in Parkinson's disease (PD). The dopaminergic system has been the main focus for almost …

Parkinson's disease is a neurodegenerative disease with motor and non-motor symptoms. In
Parkinson's disease, a neurotransmitter imbalance occurs in the extrapyramidal system with …

Parkinson's disease, often known as PD, is a more common age-related neurological
disorder that affects a huge number of older adults worldwide. Parkinson's disease is …